BioHealth News Archive
209 PERRY PARKWAY – GAITHERSBURG, MARYLAND, 20877
SPACE FEATURES Existing laboratory suite with closed and open o ices Grade-level loading doors 17' ceiling heights • breakroom with kitchenette 180 free surface…
Read MoreWhat It Takes to Manufacture a Vaccine | NAM
You may not know it, but one company has the capacity to manufacture bulk drug substance for more than a billion doses of COVID-19…
Read MoreLeveraging Artificial Intelligence in Human Health | B.S. in Biocomputational Engineering
The University of Maryland hosted a free webinar, Leveraging Artificial Intelligence in Human Health, on Friday, March 19, 2020. This event featured a fireside chat with Dr. Robert…
Read MoreNorthern Virginia’s bioscience industry grows stronger | WTOP
Exciting things are happening at Innovation Park in Manassas. Researchers are working on global solutions, industry jobs are on the rise, and new facilities…
Read MoreKnowing Your Assets with Richard Bendis Talent Talks Ep. 14
Check out this weeks episode of Talent Talks on YouTube and Spotify! This week we sit with Richard Bendis President and CEO of BioHealth…
Read More5 Questions with Natalie McKinney, Industry Programs Director, Biologics, US Pharmacopeia · BioBuzz
“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…
Read MoreConstruction on New Buildings Underway at Port Covington Development
New buildings are now rising out of the ground on the first major phase of construction at the 235-acre, $5.5-billion, multi-decade Port Covington development.…
Read MoreCASI Pharmaceuticals Announces Pricing Of $32,500,000 Public Offering Of Common Stock
ROCKVILLE, Md. and BEIJING, March 24, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative…
Read MoreNeoImmuneTech Announces Closing of Initial Public Offering – BioHealth Capital Region
ROCKVILLE, Md.–(BUSINESS WIRE)–NeoImmuneTech, Inc. (KOSDAQ: 950220), a clinical-stage T cell-focused biopharmaceutical company, today announced the closing of its initial public offering of 3,133,334 shares…
Read MoreTribute in Light: AstraZeneca Gaithersburg Campus Honors José Baselga
Our AstraZeneca Gaithersburg Campus will be illuminated this week to pay tribute to José Baselga, our beloved Oncology R&D leader and Site Head who…
Read MoreBethesda’s BrainScope launches Concussion Index, eyes big raise – Washington Business Journal
BrainScope received FDA clearance in September 2016 to sell its first product, which it developed with the Department of Defense to assess a range…
Read MoreNovavax trials highlight Maryland’s COVID-fighting complex
When Novavax Inc. received $1.6 billion last year from the federal government to speed up testing and production of a coronavirus vaccine, some observers…
Read MoreBio Lab Pilot Program — MCEDC
Rockville, Md. — The Montgomery County Economic Development Corporation (MCEDC) awarded a total of $96,430 to six small life science companies as part of its recently…
Read MoreTEDCO Announces Request for Applications for the Agriculture and Rural Rebuild Challenge | TEDCO
COLUMBIA, Md. (March 25, 2021) –TEDCO, Maryland’s economic engine for technology companies, announced today its request for applications for the Agriculture and Rural Rebuild…
Read MoreCritical need for electrophysiology devices to treat pediatric heart patients is focus of medical device pitch competition with $150K in awards | BioSpace
WASHINGTON, March 23, 2021 /PRNewswire/ -- Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often…
Read More